|
Market Closed -
Nasdaq
16:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.3810 USD | +0.05% |
|
-1.32% | -86.68% |
| 07-15 | Immutep highlights encouraging survival data and key clinical milestones | FI |
| 07-14 | Immutep Granted New US Patent for Cancer Treatment Methods | MT |
Company Valuation: Immutep Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 411.5 | 247.7 | 374 | 420.2 | 350.5 | 73.69 | - | - |
| Change | - | -39.8% | 50.99% | 12.36% | -16.6% | -78.98% | - | - |
| Enterprise Value (EV) 1 | 350.9 | 169.2 | 251.4 | 259.4 | 284.2 | 8.688 | -3.493 | 8.58 |
| Change | - | -51.79% | 48.63% | 3.18% | 9.55% | -96.94% | -140.2% | 345.67% |
| P/E | -10.9x | -7.65x | -7.05x | -8.29x | -5.69x | -1.29x | -1.84x | -1.29x |
| PBR | - | 2.62x | 2.74x | 2.26x | 2.43x | 0.87x | 0.89x | 1.2x |
| PEG | - | 0.3x | -0.4x | 0.4x | -0.3x | 0.16x | 0.1x | -0x |
| Capitalization / Revenue | - | 36.7x | 71.9x | 53.6x | 33.9x | 4.28x | 23.3x | 21x |
| EV / Revenue | - | 25x | 48.3x | 33.1x | 27.5x | 0.5x | -1.11x | 2.45x |
| EV / EBITDA | -20x | -5.63x | -6.65x | -6.42x | -4.82x | -0.16x | 0.06x | -0.12x |
| EV / EBIT | -17.9x | -5.27x | -6.31x | -6.08x | -4.63x | -0.14x | 0.06x | -0.11x |
| EV / FCF | -19.9x | -5.59x | -7.09x | 7.46x | -4.58x | -0.15x | 0.06x | -0.11x |
| FCF Yield | -5.03% | -17.9% | -14.1% | 13.4% | -21.8% | -646% | 1,654% | -893% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.0503 | -0.0379 | -0.0447 | -0.0356 | -0.0422 | -0.0387 | -0.0272 | -0.0389 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | 6.758 | 5.2 | 7.839 | 10.33 | 17.23 | 3.157 | 3.509 |
| EBITDA 1 | -17.59 | -30.05 | -37.81 | -40.42 | -59.01 | -55.15 | -57.23 | -70.64 |
| EBIT 1 | -19.66 | -32.12 | -39.88 | -42.69 | -61.4 | -64.24 | -63.2 | -81.42 |
| Net income 1 | -29.9 | -32.21 | -39.9 | -42.72 | -61.43 | -58.54 | -47.05 | -66.75 |
| Net Debt 1 | -60.59 | -78.54 | -122.6 | -160.8 | -66.3 | -65 | -77.18 | -65.11 |
| Reference price 2 | 0.5500 | 0.2900 | 0.3150 | 0.2950 | 0.2400 | 0.0500 | 0.0500 | 0.0500 |
| Nbr of stocks (in thousands) | 748,153 | 854,123 | 1,187,306 | 1,424,548 | 1,460,390 | 1,473,721 | - | - |
| Announcement Date | 8/30/21 | 8/31/22 | 8/29/23 | 8/29/24 | 8/28/25 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 34.28x | 6.11x | 18.18x | 0.94% | 50.47B | |
| -21.19x | 258.61x | -22.63x | -.--% | 44.56B | |
| 33.71x | 3.27x | 14.1x | -.--% | 43.08B | |
| 48.04x | 5.57x | 30.46x | -.--% | 41.7B | |
| 28.96x | 8.75x | 22.11x | 0.4% | 33.21B | |
| 34.16x | 5.6x | 25.43x | -.--% | 16.77B | |
| 24.12x | 2.1x | 9.08x | 1.12% | 14.58B | |
| 77.98x | 4.1x | 15.89x | -.--% | 13.92B | |
| Average | 32.51x | 36.76x | 14.08x | 0.31% | 32.28B | |
| Weighted average by Cap. | 27.93x | 49.08x | 12.78x | 0.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IMM Stock
- IMMP Stock
- Valuation Immutep Limited
Select your edition
All financial news and data tailored to specific country editions
